Aeon Global Health Corp. Receivables Turnover Ratio (AGHC), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Aeon Global Health Corp.  (AGHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Aeon Global Health Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Aeon Global Health Corp.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2019 to a ratio of 5.93, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the fourth quarter 2019. Average receivable collection period, for the Aeon Global Health in Jun 30 2019 quarter, has decreased to 62 days, compared to 64 days, in the Dec 31 2018 quarter.

If we take a look into Healthcare sector 17 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 204, from overall ranking in the second quarter 2019 at 1412.

What is Receivable Turnover Ratio?
What is Aeon Global Health Corp. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AGHC Receivables Turnover Ratio (Jun 30 2019)
IV. Quarter		 (Dec 31 2018)
II. Quarter		 (Sep 30 2018)
I. Quarter		 (Jun 30 2018)
IV. Quarter		 (Mar 31 2018)
III. Quarter
Y / Y Receivable Change -42.2 % - - - -
Y / Y Revenue Change -24.59 % - - - -
Receivable Turnover Ratio (TTM) 5.93 5.67 5.67 5.73 6.09
AGHC's Total Ranking # 204 # 1412 # 0 # 0 #
Accounts Receivable average collection period days 62 64 64 64 60
Seq. Receivable Change -38.17 % -7.73 % 7.73 % -5.95 % -
Seq. Revenue Change -13.73 % -5.24 % 11.47 % -17.24 % -


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 18
Overall Market # 204

Receivable Turnover Ratio Statistics
High Average Low
2.34 2.22 2.11
(Jun 30 2019)   (Dec 31 2018)





AGHC Company Profile • Back to AGHC Efficiency Comparisons • Compare AGHC Receivables Turnover Ratio to its Competitors

Financial Statements
Aeon Global Health's Accounts Receivable $ 2 Millions Visit AGHC's Balance sheet
Aeon Global Health's Sales TTM $ 14 Millions Visit AGHC's Income Statement
Sources of AGHC's Revenues Visit AGHC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AGHC's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AGHC's Growth Rates AGHC's Roa AGHC's Inventory Turnover Ratio AGHC's Dividend Comparisons
AGHC's Profitability Ratios AGHC's Roi AGHC's Asset Turnover Ratio AGHC's Dividend Growth
AGHC's Valuation Ratios AGHC's Roe AGHC's Financial Strength Ratios AGHC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2019 Receivable at quarter ending Jun 30 2019
Harrow Inc   23.78 $ 47.929  Millions$ 2.016  Millions
Momenta Pharmaceuticals inc   23.57 $ 67.001  Millions$ 2.843  Millions
Vtv Therapeutics Inc   23.37 $ 10.646  Millions$ 0.456  Millions
Healthlynked Corp  22.68 $ 2.720  Millions$ 0.120  Millions
Bespoke Extracts Inc  22.65 $ 0.072  Millions$ 0.003  Millions
Optinose Inc   22.13 $ 16.078  Millions$ 0.727  Millions
Ernexa Therapeutics Inc   21.95 $ 21.965  Millions$ 1.001  Millions
Advanced Container Technologies Inc   21.88 $ 2.070  Millions$ 0.095  Millions
Fate Therapeutics Inc   21.70 $ 8.136  Millions$ 0.375  Millions
Arvinas Inc   21.40 $ 14.848  Millions$ 0.694  Millions
Igc Pharma Inc   21.30 $ 5.287  Millions$ 0.248  Millions
Concert Pharmaceuticals Inc   20.73 $ 1.078  Millions$ 0.052  Millions
Tearlab Corp  19.91 $ 23.521  Millions$ 1.182  Millions
Ibio inc   19.78 $ 2.018  Millions$ 0.102  Millions
Vystar Corporation  19.62 $ 0.656  Millions$ 0.033  Millions
Mimedx Group Inc   19.35 $ 313.537  Millions$ 16.200  Millions
Seres Therapeutics Inc   19.12 $ 39.536  Millions$ 2.068  Millions
Paratek Pharmaceuticals Inc   17.20 $ 20.710  Millions$ 1.204  Millions
Cue Biopharma Inc   16.89 $ 2.205  Millions$ 0.131  Millions
Cv Sciences Inc   16.68 $ 59.590  Millions$ 3.573  Millions
Sintx Technologies Inc   16.48 $ 6.931  Millions$ 0.421  Millions
Ainos Inc   15.20 $ 0.026  Millions$ 0.002  Millions
Chemed Corporation  15.18 $ 1,837.277  Millions$ 121.048  Millions
Plx Pharma Inc   14.92 $ 1.005  Millions$ 0.067  Millions
Kyntra Bio Inc   14.19 $ 352.510  Millions$ 24.837  Millions
Corcept Therapeutics Inc  14.14 $ 268.362  Millions$ 18.985  Millions
Acadia Healthcare Company Inc   14.07 $ 4,719.665  Millions$ 335.521  Millions
Nuo Therapeutics Inc   13.85 $ 1.156  Millions$ 0.083  Millions
Mannkind Corporation  13.66 $ 52.950  Millions$ 3.875  Millions
Musclepharm Corporation  13.31 $ 83.173  Millions$ 6.251  Millions

Date modified: 2026-10-15T05:23:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.